![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | COBL | Human | (+)-schisandrin B | multiple interactions | ISO | Cobl (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of COBL mRNA] | CTD | PMID:31150632 | COBL | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COBL mRNA | CTD | PMID:36331819 | COBL | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of COBL mRNA | CTD | PMID:22206623 | COBL | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COBL mRNA | CTD | PMID:22206623 | COBL | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of COBL mRNA | CTD | PMID:23019147 | COBL | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of COBL mRNA | CTD | PMID:30165855 | COBL | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of COBL mRNA | CTD | PMID:19933214 | COBL | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of COBL mRNA | CTD | PMID:34747641 | COBL | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of COBL mRNA | CTD | PMID:21215274 and PMID:33387578 | COBL | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Cobl (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | COBL | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of COBL mRNA | CTD | PMID:28522335 | COBL | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | Cobl (Mus musculus) | 6480464 | bisphenol S results in increased expression of COBL mRNA | CTD | PMID:30951980 | COBL | Human | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of COBL gene | CTD | PMID:31601247 | COBL | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Cobl (Mus musculus) | 6480464 | Fenretinide results in increased expression of COBL mRNA | CTD | PMID:28973697 | COBL | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | Fenretinide results in decreased expression of COBL mRNA | CTD | PMID:28973697 | COBL | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of COBL protein | CTD | PMID:20106945 | COBL | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of COBL intron | CTD | PMID:30157460 | COBL | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of COBL mRNA | CTD | PMID:21641981 | COBL | Human | aflatoxin B1 | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of COBL mRNA | CTD | PMID:19770486 | COBL | Human | belinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COBL mRNA | CTD | PMID:27188386 | COBL | Human | benzo[a]pyrene | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of COBL mRNA | CTD | PMID:19770486 | COBL | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of COBL intron | CTD | PMID:30157460 | COBL | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of COBL promoter | CTD | PMID:27901495 | COBL | Human | benzo[a]pyrene | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COBL mRNA | CTD | PMID:27858113 | COBL | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of COBL mRNA | CTD | PMID:20106945 more ... | COBL | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 more ... | COBL | Human | benzo[b]fluoranthene | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of COBL mRNA | CTD | PMID:26377693 | COBL | Human | benzo[b]fluoranthene | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COBL mRNA | CTD | PMID:27858113 | COBL | Human | bisphenol A | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of COBL mRNA | CTD | PMID:25181051 | COBL | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of COBL gene | CTD | PMID:31601247 | COBL | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of COBL gene | CTD | PMID:31601247 | COBL | Human | bisphenol A | increases expression | ISO | Cobl (Mus musculus) | 6480464 | bisphenol A results in increased expression of COBL mRNA | CTD | PMID:30245210 more ... | COBL | Human | caffeine | affects expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Caffeine affects the expression of COBL mRNA | CTD | PMID:20864626 | COBL | Human | caffeine | affects phosphorylation | EXP | | 6480464 | Caffeine affects the phosphorylation of COBL protein | CTD | PMID:35688186 | COBL | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of COBL mRNA | CTD | PMID:25979313 | COBL | Human | carbon nanotube | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of COBL mRNA | CTD | PMID:25554681 | COBL | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to COBL gene] | CTD | PMID:28238834 | COBL | Human | chlordecone | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | Chlordecone results in decreased expression of COBL mRNA | CTD | PMID:33711761 | COBL | Human | chromium(6+) | affects expression | ISO | Cobl (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of COBL mRNA | CTD | PMID:28472532 | COBL | Human | chrysene | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COBL mRNA | CTD | PMID:27858113 | COBL | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of COBL mRNA | CTD | PMID:27392435 | COBL | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of COBL mRNA | CTD | PMID:27392435 | COBL | Human | cobalt dichloride | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | cobaltous chloride results in decreased expression of COBL mRNA | CTD | PMID:24386269 | COBL | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of COBL mRNA | CTD | PMID:19549813 | COBL | Human | copper(II) sulfate | increases expression | ISO | Cobl (Mus musculus) | 6480464 | Copper Sulfate results in increased expression of COBL mRNA | CTD | PMID:18579281 | COBL | Human | coumarin | affects phosphorylation | EXP | | 6480464 | coumarin affects the phosphorylation of COBL protein | CTD | PMID:35688186 | COBL | Human | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of COBL mRNA | CTD | PMID:19167446 | COBL | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of COBL mRNA | CTD | PMID:20106945 and PMID:25562108 | COBL | Human | diuron | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of COBL mRNA | CTD | PMID:21551480 | COBL | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | COBL | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of COBL mRNA | CTD | PMID:29803840 | COBL | Human | endosulfan | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of COBL mRNA | CTD | PMID:29391264 | COBL | Human | entinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COBL mRNA | CTD | PMID:27188386 | COBL | Human | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of COBL mRNA | CTD | PMID:26272509 | COBL | Human | ethanol | affects splicing | ISO | Cobl (Mus musculus) | 6480464 | Ethanol affects the splicing of COBL mRNA | CTD | PMID:30319688 | COBL | Human | etoposide | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | Etoposide results in decreased expression of COBL mRNA | CTD | PMID:25270620 | COBL | Human | fenfluramine | increases expression | EXP | | 6480464 | Fenfluramine results in increased expression of COBL mRNA | CTD | PMID:22140631 | COBL | Human | folic acid | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COBL mRNA | CTD | PMID:22206623 | COBL | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of COBL protein | CTD | PMID:37730182 | COBL | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] affects the methylation of COBL gene | CTD | PMID:31601247 | COBL | Human | gentamycin | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of COBL mRNA | CTD | PMID:22061828 | COBL | Human | glyphosate | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Glyphosate results in decreased expression of COBL mRNA | CTD | PMID:38314887 | COBL | Human | inulin | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of COBL mRNA | CTD | PMID:36331819 | COBL | Human | lipopolysaccharide | increases expression | ISO | Cobl (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of COBL mRNA | CTD | PMID:12057914 | COBL | Human | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of COBL mRNA | CTD | PMID:23179753 and PMID:26272509 | COBL | Human | methylmercury chloride | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COBL mRNA | CTD | PMID:27188386 | COBL | Human | mitomycin C | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | Mitomycin results in decreased expression of COBL mRNA | CTD | PMID:25270620 | COBL | Human | N-nitrosodiethylamine | increases expression | ISO | Cobl (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of COBL mRNA | CTD | PMID:24535843 | COBL | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of COBL mRNA | CTD | PMID:24768652 and PMID:25583101 | COBL | Human | O-methyleugenol | decreases expression | EXP | | 6480464 | methyleugenol results in decreased expression of COBL mRNA | CTD | PMID:32234424 | COBL | Human | p-toluidine | increases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | 4-toluidine results in increased expression of COBL mRNA | CTD | PMID:27638505 | COBL | Human | panobinostat | increases expression | EXP | | 6480464 | panobinostat results in increased expression of COBL mRNA | CTD | PMID:26272509 | COBL | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COBL mRNA | CTD | PMID:27188386 | COBL | Human | paracetamol | affects expression | ISO | Cobl (Mus musculus) | 6480464 | Acetaminophen affects the expression of COBL mRNA | CTD | PMID:17562736 | COBL | Human | paracetamol | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of COBL mRNA | CTD | PMID:32479839 and PMID:33387578 | COBL | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of COBL mRNA | CTD | PMID:21420995 more ... | COBL | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COBL mRNA more ... | CTD | PMID:36331819 | COBL | Human | phenobarbital | increases expression | ISO | Cobl (Mus musculus) | 6480464 | Phenobarbital results in increased expression of COBL mRNA | CTD | PMID:19482888 | COBL | Human | phenobarbital | affects expression | ISO | Cobl (Mus musculus) | 6480464 | Phenobarbital affects the expression of COBL mRNA | CTD | PMID:23091169 | COBL | Human | phenobarbital | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of COBL mRNA] | CTD | PMID:19482888 | COBL | Human | pirinixic acid | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of COBL mRNA | CTD | PMID:19710929 | COBL | Human | pirinixic acid | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of COBL mRNA | CTD | PMID:20813756 | COBL | Human | propanal | increases expression | EXP | | 6480464 | propionaldehyde results in increased expression of COBL mRNA | CTD | PMID:26079696 | COBL | Human | propiconazole | increases expression | ISO | Cobl (Mus musculus) | 6480464 | propiconazole results in increased expression of COBL mRNA | CTD | PMID:21278054 | COBL | Human | resveratrol | increases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | resveratrol results in increased expression of COBL mRNA | CTD | PMID:19228061 | COBL | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of COBL mRNA | CTD | PMID:23557933 | COBL | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | COBL | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of COBL mRNA | CTD | PMID:38568856 | COBL | Human | sodium arsenite | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of COBL mRNA | CTD | PMID:37682722 | COBL | Human | Soman | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Soman results in decreased expression of COBL mRNA | CTD | PMID:19281266 | COBL | Human | spermine | increases expression | ISO | Cobl (Mus musculus) | 6480464 | Spermine results in increased expression of COBL mRNA | CTD | PMID:18673383 | COBL | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of COBL mRNA | CTD | PMID:31533062 | COBL | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of COBL mRNA | CTD | PMID:33359661 | COBL | Human | tetrachloromethane | multiple interactions | ISO | Cobl (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of COBL mRNA] | CTD | PMID:31150632 | COBL | Human | tetrachloromethane | increases expression | ISO | Cobl (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of COBL mRNA | CTD | PMID:31919559 | COBL | Human | tetrachloromethane | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of COBL mRNA | CTD | PMID:31150632 | COBL | Human | tetraphene | decreases expression | ISO | Cobl (Mus musculus) | 6480464 | benz(a)anthracene results in decreased expression of COBL mRNA | CTD | PMID:26377693 | COBL | Human | tetraphene | multiple interactions | ISO | Cobl (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COBL mRNA | CTD | PMID:27858113 | COBL | Human | thioacetamide | increases methylation | ISO | Cobl (Rattus norvegicus) | 6480464 | Thioacetamide results in increased methylation of COBL promoter | CTD | PMID:27914986 | COBL | Human | thioacetamide | decreases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of COBL mRNA | CTD | PMID:34492290 | COBL | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of COBL mRNA | CTD | PMID:38568856 | COBL | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of COBL mRNA | CTD | PMID:24935251 and PMID:26272509 | COBL | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COBL mRNA | CTD | PMID:27188386 | COBL | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of COBL mRNA | CTD | PMID:30510588 | COBL | Human | triphenyl phosphate | increases expression | ISO | Cobl (Rattus norvegicus) | 6480464 | triphenyl phosphate results in increased expression of COBL mRNA | CTD | PMID:30589522 | COBL | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of COBL mRNA | CTD | PMID:23179753 more ... | COBL | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COBL mRNA | CTD | PMID:27188386 | COBL | Human | vinclozolin | affects expression | ISO | Cobl (Mus musculus) | 6480464 | vinclozolin affects the expression of COBL mRNA | CTD | PMID:21636974 | |